Answers are grounded in this paper and cite their sources.
Analysis evaluates cardiovascular disease risk models during COVID-19, indicating no need for adaptation.
The SCORE2-FOMs demonstrated good calibration and discrimination, suggesting that no adaptation is needed in response to the COVID-19 pandemic. Short-term EHRs provide a valuable resource for timely contemporary risk model validation and, if necessary, for adaptation according to shifts in CVD trends.
No takes yet. Share an insight, caveat, or question.
Petitjean et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: